Advertisement Fidelity
Home > Boards > US OTC > Biotechs >

Amarantus BioScience Holdings, Inc. (AMBS)

AMBS RSS Feed
Add AMBS Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator r00kie, joboggi, brickbybrick, Natural Treasures, longboardsurfer90210
Search This Board:
Last Post: 4/20/2014 4:01:07 AM - Followers: 650 - Board type: Free - Posts Today: 2

yes
 



(This "Intro Box" is NOT maintained by Amarantus BioScience, Inc. and is intended solely as a quick information source on ihub.  For more detailed, up-to-date information on Amarantus BioScience, Inc., please go the company website.)
 

Amarantus is a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and protein misfolding-related apoptosis. The company has licensed Eltoprazine, a Phase 2B ready Parkinsons Levadopa induced Dyskinesia. The company has an exclusive worldwide license to the Lymphocyte Proliferation test ("LymPro Test®") for Alzheimer's Disease and owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor ("MANF") and is developing MANF-based products as treatments for brain disorders. Amarantus is a Founding Member of the Coalition for Concussion Treatment (#C4CT), a movement initiated in collaboration with Brewer Sports International seeking to raise awareness of new treatments in development for concussions and nervous-system disorders. The Company also owns intellectual property rights for the diagnosis of Parkinson's Disease ("NuroPro") and the discovery of neurotrophic facotrs ("PhenoGuard"). For furtherinformation, please visit www.Amarantus.com, or connect with the company on Facebook, LinkedIn, Twitter and Google+.

Amarantus' Management Team and Board of Advisors have designed a business strategy to formulate and advance pre-clinical and clinical programs for the Company's product candidates through successive de-risking milestones in order to maximize their commercial potential. The Company is also focused on making the assets attractive partnering targets for product development focused biotechnology, pharmaceutical, medical device and diagnostic companies.

 
SHARE STRUCTURE
643,210,764 million shares oustanding as of March 6, 2014


TRANSFER AGENT
Stock Transfer, LLC
77 Spruce Street, Suite 201
Cedarhurst, NY 11516
Attention: Yoel Goldfeder
Phone: 212-828-8436
Toll-Free: 855-9VSTOCK
Fax: 646-536-3179



USEFUL LINKS:

DAILY CHART


EDGAR (SEC) FILINGS

PRESS RELEASES & NEWS ARTICLES


VIDEOS/AUDIO

Amarantus at LD Micro 6th Annual Conference, December 3, 2013

 



Medical Dictionary (some often-used terms in AMBS PRs)

The substania nigra is an area of pigmented cells in the midbrain which is responsible for producing the neurotransmitter dopamine. This section of the brain plays an important role in the control of movement, and it also appears to interact in the process of addiction, as well. If you view a brain in cross-section, the substantia nigra is located in the midbrain, right at the tip of the brainstem.

The striatum is also called the striate body. It includes the caudate nucleus and the lentiform nucleus. The term striatum (striate) refers to the layered appearance of bands of gray matter that course from one of these nuclei to the other and represent the connections between them.

In living tissues, reinnervation describes the process by which post-synaptic neurons form new synapses or increase existing synaptic efficacy in order to compensate for a lack of pre-synaptic input from dead or otherwise dysfunctional pre-synaptic neurons.


Glial cell-derived neurotrophic factor, also known as GDNF is a protein that, in humans, is encoded by the GDNF gene.[1] GDNF is a small protein that potently promotes the survival of many types of neurons.[2

Myocardial infarction (MI) or acute myocardial infarction (AMI), commonly known as a heart attack

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Pertinent Terms of Service

A. Is unlawful, threatening, abusive, harassing, defamatory, libelous, vulgar, hateful, deceptive, fraudulent, invasive of another's privacy, tortious, contains explicit or graphic descriptions or accounts of sexual acts (including but not limited to sexual language of a violent or threatening nature directed at another individual or group of individuals), or otherwise violates our rules or policies; This includes signatures as well. 
B. Attacks, verbally or otherwise, any other user, the website, any non-public figure, or any agents or employees of iHub; This includes signatures as well. 
C. Victimizes, harasses, degrades, or intimidates an individual or group of individuals on the basis of religion, gender, sexual orientation, race, ethnicity, age, or disability; This includes signatures as well. 

 




  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMBS
Current Price
Volume:
Bid Ask Day's Range
Wiki
AMBS News: Amarantus Appoints Dr. Charlotte Keywood Chief Medical Officer of Its Therapeutics Division 04/08/2014 06:00:00 AM
AMBS News: Amarantus Appoints Robert Farrell, J.D. as Chief Financial Officer 04/01/2014 06:00:00 AM
AMBS News: Amarantus Appoints Dr. Louis Kirby to Board of Advisors 03/31/2014 08:30:00 AM
AMBS News: Cavendish Selects Amarantus to Present at the Cavendish Global Health Impact Forum 03/26/2014 08:00:00 AM
AMBS News: Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC 03/10/2014 06:00:00 AM
PostSubject
#98701  Sticky Note AMBS is holding its own. Natural Treasures 04/03/14 09:12:30 PM
#94873  Sticky Note Current Milestones & Catalysts brickbybrick 02/10/14 03:46:28 PM
#93343  Sticky Note Amarantus CEO intends to up-list to a national WarpCore61 01/22/14 07:36:31 PM
#91837  Sticky Note Gerald continues to deliver! His blog set the gipper 01/13/14 09:56:07 PM
#74467  Sticky Note MJFF is firm with their notion that NFs joboggi 05/22/13 11:25:08 PM
#53611  Sticky Note SECOND BOARD WARNING! IH Admin [Dan] 02/02/13 05:38:48 PM
#99557   sumo, the share price got hammered last year WarpCore61 04/20/14 04:01:07 AM
#99556   Momentum is clearly to the downside with AMBS sumotrader 04/20/14 02:15:48 AM
#99555   If the company is on time and is Inoviorulez 04/19/14 11:02:59 PM
#99554   As I have mentioned in a previous posting Inoviorulez 04/19/14 10:57:20 PM
#99553   About 70 more days max. Tanis2476 04/19/14 09:35:51 PM
#99552   3 more months of this BS. I hope Zaadx 04/19/14 07:29:42 PM
#99551   Exactly. Couldn't have said it better myself. Good Post. veeets 04/19/14 07:20:02 PM
#99550   Eltoprazine could really take treatment to a whole Natural Treasures 04/19/14 06:25:50 PM
#99549   Dyskinesia: Hope on the Horizon http://www.youtube.com/watch?v=bwg7W7sJdHI&sns=t zoomboom 04/19/14 05:14:34 PM
#99548   A good place to start to conduct your Solantey 04/19/14 03:00:59 PM
#99547   does anyone here know how many companies will donl1955 04/19/14 02:42:10 PM
#99546   keeping more than my fingers crossed that we Angry Goat 04/19/14 02:29:36 PM
#99545   Thanks JP and RR, forgot about that. seebisquick 04/19/14 02:17:08 PM
#99544   Cavendish Conference in Manhattan - see news item JPetroInc 04/19/14 02:14:56 PM
#99543   The Cavendish Conference is around that time when Riskreturn168 04/19/14 02:14:13 PM
#99542   JP, what's May 5th for AMBS? seebisquick 04/19/14 02:09:38 PM
#99541   Visit Dr. Urano's blog today for his new garydaemon 04/19/14 01:23:12 PM
#99540   All quiet on the Westwrn Front - that JPetroInc 04/19/14 01:07:24 PM
#99539   The late filing is most likely due to Riskreturn168 04/19/14 12:32:00 PM
#99538   I agree with everything you have stated. Also Inoviorulez 04/19/14 08:44:19 AM
#99537   budddddddddy DSW.. I am delusional? hahahahahahaah.. Actually may christjamin 04/18/14 10:42:12 PM
#99536   Better question, why are you still here? jacmar1965 04/18/14 07:58:21 PM
#99535   I have a huge holding now of AMBS Inoviorulez 04/18/14 07:29:48 PM
#99534   This Monday. calm61 04/18/14 06:39:58 PM
#99533   I am out at .075. Any suggestions when Vis567 04/18/14 06:34:49 PM
#99532   I just don't see the point of conjecturing. christjamin 04/18/14 06:33:25 PM
#99531   Gerald may not have been involved in the WarpCore61 04/18/14 05:51:29 PM
#99530   He wasn't paid $500,000 per year. Solantey 04/18/14 05:34:59 PM
#99529   I'm checking out for the weekend. It's Calm68 04/18/14 05:34:01 PM
#99528   You are like a little child with too calm61 04/18/14 05:23:07 PM
#99527   You can sugarcoat every mistake this company makes, dsw 04/18/14 05:16:55 PM
#99526   Sound post JPetroInc 04/18/14 04:30:29 PM
#99525   Exactly. Why I lean in the 'In Calm68 04/18/14 03:32:19 PM
#99524   the infamous "E" designation will determine that JPetroInc 04/18/14 01:52:47 PM
#99523   I wonder why GC didnt just lay off dsw 04/18/14 01:30:40 PM
#99522   With an extension approved by the SEC, the jeffshir 04/18/14 12:42:48 PM
#99521   Ah, the dreaded "F" word. Certainly Marcum would Loco Motion 04/18/14 12:14:53 PM
#99520   JP: I would be more worried about Lincoln Riskreturn168 04/18/14 12:06:12 PM
#99519   Ahhhhhh......quiet. Level heads prevail. Some really nice posts longboardsurfer90210 04/18/14 11:47:03 AM
#99518   If Mr. Farrell needed a few extra days Solantey 04/18/14 11:36:21 AM
#99517   Bingo, AMBS love and hate in a nutshell. Loco Motion 04/18/14 11:34:41 AM
#99516   Risk, the entire point of the filing being JPetroInc 04/18/14 11:26:29 AM
#99515   How can we view current events with a Loco Motion 04/18/14 11:20:57 AM
#99514   pragmatic post... JPetroInc 04/18/14 10:48:25 AM
#99513   Excellent Summary Tanis! Riskreturn168 04/18/14 10:26:55 AM
#99512   Informative post. The key is to get this Angry Goat 04/18/14 10:24:15 AM
#99511   I am fully on board also. Good post, Loco Motion 04/18/14 10:04:11 AM
#99510   Your insights are appreciated. Solantey 04/18/14 09:56:14 AM
#99509   So nice and quiet with the market closed Tanis2476 04/18/14 09:46:41 AM
#99508   Uplisting it''s a possibility but Gerald sante1 04/18/14 04:01:17 AM
PostSubject